PointState Capital’s Alkermes ALKS Stock Holding History

PointState Capital’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,258,000	Closed	-$73.6M	–	137
2017 Q1	$73.6M	Buy	1,258,000 +736,700	+141%	+$41.8M	0.77%	37
2016 Q4	$29M	Buy	+521,300	New	+$27.9M	0.42%	60
2014 Q1	–	Sell	-1,200,000	Closed	-$48.8M	–	119
2013 Q4	$48.8M	Buy	1,200,000 +700,000	+140%	+$25.9M	0.62%	44
2013 Q3	$16.8M	Buy	+500,000	New	+$16.3M	0.29%	66

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PointState Capital's ALKS Position: Q2 2017 in Review

PointState Capital sold out of Alkermes (ALKS) in Q2 2017, closing a stake of 1,258,000 shares — an estimated $73.6M sold.

PointState Capital first reported a position in ALKS in Q3 2013 and held it in 4 quarters. The position peaked at $73.6M in Q1 2017. 256 funds tracked by Wall St. Rank hold ALKS as of Q2 2017.

PointState Capital reported no remaining Alkermes position as of Q2 2017 after selling out during the quarter.
PointState Capital sold 1,258,000 Alkermes shares in Q2 2017, an estimated $73.6M.
PointState Capital first reported a position in Alkermes in Q3 2013 and held it in 4 quarters.
PointState Capital's Alkermes position peaked at $73.6M in Q1 2017.
256 funds tracked by Wall St. Rank held Alkermes as of Q2 2017.

Based on PointState Capital's 13F filing for Q2 2017, filed 14 Aug 2017.